Early treatment response in non-small cell lung cancer patients using diffusion-weighted imaging and functional diffusion maps--a feasibility study.

<h4>Objective</h4>The aim of this study was to prospectively evaluate the feasibility of monitoring treatment response to chemotherapy in patients with non-small cell lung carcinoma using functional diffusion maps (fDMs).<h4>Materials and methods</h4>This study was approved b...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Carolin Reischauer, Johannes Malte Froehlich, Miklos Pless, Christoph Andreas Binkert, Dow-Mu Koh, Andreas Gutzeit
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2014
Materias:
R
Q
Acceso en línea:https://doaj.org/article/a9ce1e2ef5d3433d920baa01a4865d0c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:a9ce1e2ef5d3433d920baa01a4865d0c
record_format dspace
spelling oai:doaj.org-article:a9ce1e2ef5d3433d920baa01a4865d0c2021-11-25T05:57:44ZEarly treatment response in non-small cell lung cancer patients using diffusion-weighted imaging and functional diffusion maps--a feasibility study.1932-620310.1371/journal.pone.0108052https://doaj.org/article/a9ce1e2ef5d3433d920baa01a4865d0c2014-01-01T00:00:00Zhttps://doi.org/10.1371/journal.pone.0108052https://doaj.org/toc/1932-6203<h4>Objective</h4>The aim of this study was to prospectively evaluate the feasibility of monitoring treatment response to chemotherapy in patients with non-small cell lung carcinoma using functional diffusion maps (fDMs).<h4>Materials and methods</h4>This study was approved by the Cantonal Research Ethics Committee and informed written consent was obtained from all patients. Nine patients (mean age = 66 years; range = 53-76 years, 5 females, 4 males) with overall 13 lesions were included. Imaging was performed within two weeks before initiation of chemotherapy and at one, two, and six weeks after initiation of chemotherapy. Imaging included a respiratory-triggered diffusion-weighted sequence including three b-factors (100, 600, and 800 s/mm2). Treatment response was defined by change in tumor diameter on computed tomography (CT) after two cycles of chemotherapy. Changes in the apparent diffusion coefficient (ADC) on a per-lesion basis and the percentages of voxel with significantly increased or decreased ADCs on fDMs were analyzed using repeated measures analysis of variance (ANOVA). Changes in tumor size were used as covariate to examine the ability of ADCs and fDM parameters to predict treatment response.<h4>Results</h4>Repeated measures ANOVA revealed that the percentage of voxels with increased ADCs on fDMs (p = 0.002) as well as the mean ADC increase (p = 0.011) were significantly higher in good responders with a large reduction in tumor size on CT.<h4>Conclusion</h4>Our results indicate that the percentage of voxels with significantly increased ADCs on fDMs seems to be a promising biomarker for early prediction of treatment response in patients with non-small cell lung carcinoma. Contrary to averaged values, this approach allows the spatial heterogeneity of treatment response to be resolved.Carolin ReischauerJohannes Malte FroehlichMiklos PlessChristoph Andreas BinkertDow-Mu KohAndreas GutzeitPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 9, Iss 10, p e108052 (2014)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Carolin Reischauer
Johannes Malte Froehlich
Miklos Pless
Christoph Andreas Binkert
Dow-Mu Koh
Andreas Gutzeit
Early treatment response in non-small cell lung cancer patients using diffusion-weighted imaging and functional diffusion maps--a feasibility study.
description <h4>Objective</h4>The aim of this study was to prospectively evaluate the feasibility of monitoring treatment response to chemotherapy in patients with non-small cell lung carcinoma using functional diffusion maps (fDMs).<h4>Materials and methods</h4>This study was approved by the Cantonal Research Ethics Committee and informed written consent was obtained from all patients. Nine patients (mean age = 66 years; range = 53-76 years, 5 females, 4 males) with overall 13 lesions were included. Imaging was performed within two weeks before initiation of chemotherapy and at one, two, and six weeks after initiation of chemotherapy. Imaging included a respiratory-triggered diffusion-weighted sequence including three b-factors (100, 600, and 800 s/mm2). Treatment response was defined by change in tumor diameter on computed tomography (CT) after two cycles of chemotherapy. Changes in the apparent diffusion coefficient (ADC) on a per-lesion basis and the percentages of voxel with significantly increased or decreased ADCs on fDMs were analyzed using repeated measures analysis of variance (ANOVA). Changes in tumor size were used as covariate to examine the ability of ADCs and fDM parameters to predict treatment response.<h4>Results</h4>Repeated measures ANOVA revealed that the percentage of voxels with increased ADCs on fDMs (p = 0.002) as well as the mean ADC increase (p = 0.011) were significantly higher in good responders with a large reduction in tumor size on CT.<h4>Conclusion</h4>Our results indicate that the percentage of voxels with significantly increased ADCs on fDMs seems to be a promising biomarker for early prediction of treatment response in patients with non-small cell lung carcinoma. Contrary to averaged values, this approach allows the spatial heterogeneity of treatment response to be resolved.
format article
author Carolin Reischauer
Johannes Malte Froehlich
Miklos Pless
Christoph Andreas Binkert
Dow-Mu Koh
Andreas Gutzeit
author_facet Carolin Reischauer
Johannes Malte Froehlich
Miklos Pless
Christoph Andreas Binkert
Dow-Mu Koh
Andreas Gutzeit
author_sort Carolin Reischauer
title Early treatment response in non-small cell lung cancer patients using diffusion-weighted imaging and functional diffusion maps--a feasibility study.
title_short Early treatment response in non-small cell lung cancer patients using diffusion-weighted imaging and functional diffusion maps--a feasibility study.
title_full Early treatment response in non-small cell lung cancer patients using diffusion-weighted imaging and functional diffusion maps--a feasibility study.
title_fullStr Early treatment response in non-small cell lung cancer patients using diffusion-weighted imaging and functional diffusion maps--a feasibility study.
title_full_unstemmed Early treatment response in non-small cell lung cancer patients using diffusion-weighted imaging and functional diffusion maps--a feasibility study.
title_sort early treatment response in non-small cell lung cancer patients using diffusion-weighted imaging and functional diffusion maps--a feasibility study.
publisher Public Library of Science (PLoS)
publishDate 2014
url https://doaj.org/article/a9ce1e2ef5d3433d920baa01a4865d0c
work_keys_str_mv AT carolinreischauer earlytreatmentresponseinnonsmallcelllungcancerpatientsusingdiffusionweightedimagingandfunctionaldiffusionmapsafeasibilitystudy
AT johannesmaltefroehlich earlytreatmentresponseinnonsmallcelllungcancerpatientsusingdiffusionweightedimagingandfunctionaldiffusionmapsafeasibilitystudy
AT miklospless earlytreatmentresponseinnonsmallcelllungcancerpatientsusingdiffusionweightedimagingandfunctionaldiffusionmapsafeasibilitystudy
AT christophandreasbinkert earlytreatmentresponseinnonsmallcelllungcancerpatientsusingdiffusionweightedimagingandfunctionaldiffusionmapsafeasibilitystudy
AT dowmukoh earlytreatmentresponseinnonsmallcelllungcancerpatientsusingdiffusionweightedimagingandfunctionaldiffusionmapsafeasibilitystudy
AT andreasgutzeit earlytreatmentresponseinnonsmallcelllungcancerpatientsusingdiffusionweightedimagingandfunctionaldiffusionmapsafeasibilitystudy
_version_ 1718414359350214656